ORIC

$0.00

(

0.00%

)
Quote details

stock

Oric Pharmaceuticals Inc

NASDAQ | ORIC

10.52

USD

$0.00

(

0.00%

)

At Close (As of Sep 17, 2025)

$1.06B

Market Cap

-

P/E Ratio

-1.89

EPS

$14.67

52 Week High

$3.89

52 Week Low

HEALTHCARE

Sector

ORIC Chart

Recent Chart
Price Action

ORIC Technicals

Tags:

ORIC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1.1M
Total Revenue $0
Cost Of Revenue $1.1M
Costof Goods And Services Sold $1.1M
Operating Income -$143M
Selling General And Administrative $29M
Research And Development $114M
Operating Expenses $142M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$128M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$128M
Comprehensive Income Net Of Tax -
Ebit -$128M
Ebitda -$127M
Net Income -$128M

Revenue & Profitability

Earnings Performance

ORIC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $274M
Total Current Assets $262M
Cash And Cash Equivalents At Carrying Value $59M
Cash And Short Term Investments $59M
Inventory -
Current Net Receivables -
Total Non Current Assets $12M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $0
Short Term Investments $197M
Other Current Assets $6.3M
Other Non Current Assets -
Total Liabilities $31M
Total Current Liabilities $25M
Current Accounts Payable $1.5M
Deferred Revenue -
Current Debt -
Short Term Debt $6.4M
Total Non Current Liabilities $6.2M
Capital Lease Obligations $3.2M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $9.4M
Other Current Liabilities $17M
Other Non Current Liabilities $6.2M
Total Shareholder Equity $243M
Treasury Stock -
Retained Earnings -$563M
Common Stock $7K
Common Stock Shares Outstanding $70M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$113M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.1M
Capital Expenditures $1.2M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $22M
Cashflow From Financing $127M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$128M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1.1M
Total Revenue $0
Cost Of Revenue $1.1M
Costof Goods And Services Sold $1.1M
Operating Income -$143M
Selling General And Administrative $29M
Research And Development $114M
Operating Expenses $142M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$128M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$128M
Comprehensive Income Net Of Tax -
Ebit -$128M
Ebitda -$127M
Net Income -$128M

ORIC News

ORIC Profile

Oric Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Oric Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focused on the discovery and development of innovative cancer therapies. The company leverages its proprietary platforms to address unmet medical needs in oncology, particularly in areas impacted by resistance to current treatments. With a robust pipeline of drug candidates targeting specific mechanisms of cancer cell survival, Oric is well-positioned to advance its clinical trials and potentially reshape treatment paradigms for patients with challenging malignancies.

ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
QBTS
+18.75%
$22.54
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
TSLA
+1.00%
$425.86
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
RGTI
+9.94%
$21.99
SOFI
-1.02%
$27.14
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
F
+0.43%
$11.66
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
INTC
-1.46%
$24.90
PGRE
-11.63%
$6.53
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
NAKA
-4.66%
$1.43
KDLY
-4.66%
$1.43
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
RIOT
+0.57%
$17.62
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
ONDS
+0.16%
$6.10
AIRE
-1.57%
$1.25
AMD
-0.81%
$159.16
LDI
+2.70%
$4.55
QS
+1.08%
$10.26
ABEV
0.00%
$2.36
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
QUBT
+4.97%
$17.71
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
RIG
-2.01%
$3.40
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
CWD
+19.05%
$7.56
JD
+1.52%
$35.24
GPUS
+6.65%
$0.41
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
RZLV
-3.60%
$7.08
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
BTE
-2.49%
$2.54
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
GDXD
+1.63%
$1.24
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35
ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
QBTS
+18.75%
$22.54
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
TSLA
+1.00%
$425.86
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
RGTI
+9.94%
$21.99
SOFI
-1.02%
$27.14
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
F
+0.43%
$11.66
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
INTC
-1.46%
$24.90
PGRE
-11.63%
$6.53
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
NAKA
-4.66%
$1.43
KDLY
-4.66%
$1.43
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
RIOT
+0.57%
$17.62
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
ONDS
+0.16%
$6.10
AIRE
-1.57%
$1.25
AMD
-0.81%
$159.16
LDI
+2.70%
$4.55
QS
+1.08%
$10.26
ABEV
0.00%
$2.36
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
QUBT
+4.97%
$17.71
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
RIG
-2.01%
$3.40
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
CWD
+19.05%
$7.56
JD
+1.52%
$35.24
GPUS
+6.65%
$0.41
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
RZLV
-3.60%
$7.08
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
BTE
-2.49%
$2.54
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
GDXD
+1.63%
$1.24
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.